Home Cart Sign in  
Chemical Structure| 6209-17-2 Chemical Structure| 6209-17-2

Structure of 6209-17-2

Chemical Structure| 6209-17-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sulfacetamide Sodium Monohydrate is a synthetic sulfanylacetamide, working by inhibiting bacterial folic acid synthesis through competing with para amino benzoic acid.

Synonyms: Sulfacetamide sodium salt hydrate; Sulfacetamide sodium salt monohydrate; Sulfacetamide(sodium monohydrate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sulfacetamide sodium monohydrate

CAS No. :6209-17-2
Formula : C8H11N2NaO4S
M.W : 254.24
SMILES Code : O=S(C1=CC=C(N)C=C1)([N-]C(C)=O)=O.[H]O[H].[Na+]
Synonyms :
Sulfacetamide sodium salt hydrate; Sulfacetamide sodium salt monohydrate; Sulfacetamide(sodium monohydrate)
MDL No. :MFCD00149555
InChI Key :IHCDKJZZFOUARO-UHFFFAOYSA-M
Pubchem ID :6419954

Safety of Sulfacetamide sodium monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.93mL

0.79mL

0.39mL

19.67mL

3.93mL

1.97mL

39.33mL

7.87mL

3.93mL

References

[1]Mohammadpour R, Safarian S, et al. Death inducing and cytoprotective autophagy in T-47D cells by two common antibacterial drugs: sulphathiazole and sulphacetamide. Cell Biol Int. 2013 Apr;37(4):348-58.

[2]Prabhu V, Lui H, et al. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides. Phytochemistry. 1997 May;45(1):23-7.

[3]Ahmed S, Anwar N, Sheraz MA, Ahmad I. Validation of a Stability-Indicating Spectrometric Method for the Determination of Sulfacetamide Sodium in Pure Form and Ophthalmic Preparations. J Pharm Bioallied Sci. 2017;9(2):126–134

[4]Wolf K, Silapunt S. The use of sodium sulfacetamide in dermatology. Cutis. 2015;96(2):128–130

[5]Del Rosso JQ. The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol. 2009;2(8):26–29

[6]Del Rosso JQ. Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. Cutis. 2004;73(1Suppl):29–33

[7]Sensoy D, Cevher E, Sarici A, Yilmaz M, Ozdamar A, Bergişadi N. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. Eur J Pharm Biopharm. 2009;72(3):487–495

[8]Colak S, Korkmaz M. Investigation of radiosterilization and dosimetric features of sulfacetamide sodium. J Pharm Biomed Anal. 2004;36(4):791–798

 

Historical Records

Categories